Publication: Benefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Findings From the Phase 3 PREVENT Study
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
WoS Q
Q1
Scopus Q
Q1
Source
Neurology
Volume
94
Issue
15